Local Institution

Chattanooga, Tennessee 37421

0 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, Cancer, Coronary Artery Disease, Diabetes Mellitus, Type 2, Heart Disease, Hepatic Cirrhosis, Ischemic Heart Disease, Leukemia, Lymphocytic, Acute, L2, Leukemia, Myeloid, Chronic, Liver Fibrosis, Metastases, Non-Small-Cell Lung Carcinoma

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis — Completed
• A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease — Stopped early
• A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress. — Stopped early
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography — Stopped early
• Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) — Completed
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed